Care365.caYour health is one click away
Menu
Vaccine product guide

IXCHIQ

Chikungunya virus, live attenuated · Chikungunya

Health Canada DIN 02548984. Check the product and formulation on your record before using a schedule.

Plan doses for this product →
DIN
02548984
Family
Chikungunya
Guidance checked
2026-09-27
← All Chikungunya products

About this vaccine

IXCHIQ helps protect adults and teens 12 and older from getting sick with chikungunya, a virus spread by mosquito bites.

IXCHIQ is listed under Health Canada DIN 02548984. The product record and monograph below describe this formulation; the dose schedule comes from the Canadian Immunization Guide.

At a glance

Brand
IXCHIQ
DIN
02548984
Vaccine
Chikungunya virus, live attenuated
Presentation
0.5 mL · powder for solution · intramuscular · authorized from 12 years; not recommended at 65 and older
Live vaccine
Yes

Age and suitability depend on the product, the person and the reason for vaccination. Use the planner for a starting point and confirm with a healthcare professional.

Official sources

Use the DIN to confirm this exact product in Health Canada's Drug Product Database.

A listed product may not be stocked or publicly funded.

Before and after your vaccination

  • Bring your immunization record if you have one, so earlier doses can be checked.
  • Tell the healthcare professional about a serious reaction to a previous vaccine or an ingredient, and mention any health conditions or medicines that could affect your vaccination.
  • After the dose, stay where you can be observed for at least 15 minutes. Tell someone right away if you feel faint or develop symptoms of an allergic reaction.
  • Keep a record of the vaccine name, date and dose you received.

These steps come from the Canadian Immunization Guide's administration practices and acute reactions guidance.

Practical guidance for IXCHIQ

The details below are adapted from a Pharmasist patient handout linked to the same product monograph. The current Canadian Immunization Guide determines the dose schedules shown later.

What this vaccine helps prevent

  • IXCHIQ helps protect adults and teens 12 and older from getting sick with chikungunya, a virus spread by mosquito bites.
  • It is often given to people traveling to parts of the world where chikungunya is common.
  • It does not protect against other diseases spread by mosquitoes, so you should still avoid mosquito bites.

What to mention before a dose

  • Tell your healthcare professional about all your health conditions before getting this vaccine.
  • Tell them if you have a weak immune system, or if you take medicine that weakens your immune system, such as high-dose steroids or cancer treatment.
  • Tell them if you have a bleeding problem or a low blood platelet count.
  • Tell them if you currently have a fever or feel very unwell, since vaccination may need to wait until you recover.
  • Tell them about any allergies, especially to a previous dose of this vaccine.

How it is given

  • A healthcare professional will give you this vaccine as a single shot into the muscle of your upper arm.
  • This is a one-time dose. Your healthcare professional will tell you if you ever need another.
  • Because this is an injection given in a clinic, food and meal timing do not affect this medicine.

Important things to know

  • Some older adults with several ongoing health problems have had serious, sometimes life-threatening reactions after this vaccine, including worsening of their existing conditions, confusion, or brain swelling.
  • Rarely, people have developed brain inflammation (encephalitis) after this vaccine, which has been fatal in some reported cases, mostly in older adults with other health problems.
  • Some people develop symptoms similar to chikungunya illness itself after the vaccine, such as fever with joint pain, muscle aches, headache, or rash, which can occasionally last for weeks or months.
  • As with any vaccine given by injection, a serious allergic reaction is possible, so you will usually be watched for a short time after your shot.

Effects you may notice

  • Headache, tiredness, muscle aches, and joint pain are common after this vaccine.
  • Fever, nausea, or a rash may also occur.
  • Soreness, redness, or swelling where you got the shot is common and usually goes away on its own.

When to contact a healthcare professional

  • Contact your healthcare professional if you develop fever along with joint pain, muscle aches, or a rash that lasts more than a couple of weeks.
  • Contact your healthcare professional if you notice ongoing joint swelling or pain after your shot.
  • Contact your healthcare professional about any side effect that bothers you or does not go away.

When to get emergency help

  • Get emergency help if you have trouble breathing, wheezing, or a hoarse voice after your shot.
  • Get emergency help if you develop hives, sudden dizziness, weakness, or a fast heartbeat.
  • Get emergency help if you become confused, have severe drowsiness, a bad headache with a stiff neck, or any sudden change in how you think or move.

Other medicines and vaccines

  • Tell your healthcare professional about every medicine, vitamin, and supplement you take before your appointment.
  • This vaccine is not usually given at the same time as other vaccines because this combination has not been studied.
  • If you have recently received immune globulin, a blood transfusion, or plasma products, tell your healthcare professional, since this can affect how well the vaccine works.

Key points to remember

  • Keep using insect repellent and other mosquito-bite precautions, even after your vaccination, since protection is not guaranteed for everyone.
  • This vaccine does not protect you from other mosquito-borne illnesses, such as dengue or Zika.
  • Keep a record of your vaccination date for your own health records and any future travel requirements.

The practical points are adapted from the Pharmasist reference for IXCHIQ and its matching product monograph.

Dose schedules

These are Canadian Immunization Guide schedules associated with this DIN. The right schedule depends on age, health, prior doses and reason for vaccination. Public health recommendations may differ from a product monograph's authorized schedule.

Chikungunya (IXCHIQ) — adults 18 to 64, one dose after a travel-health assessment

1 dose

One dose of live chikungunya vaccine; not routinely recommended, considered only for people at high risk of exposure.

CATMAT: IXCHIQ is generally not recommended for adults 18 to 64 years of age but may be considered for individuals at high risk of infection; it is not recommended at 65 years of age and older (serious adverse events, including deaths, reported mostly in older adults). Health Canada authorizes it from 12 years. Contraindicated in pregnancy and with a weakened immune system.

Check your dose plan →

Pregnancy and breastfeeding

Family guidance on pregnancy: Generally contraindicated: a live vaccine. Avoid pregnancy for one month after vaccination.

Family guidance on breastfeeding: Limited data; an individual assessment with a healthcare provider.

This guidance applies to the vaccine family. Confirm this product's details in the monograph and with your clinician. Immunization in pregnancy and breastfeeding: Canadian Immunization Guide — Chapter updated August 2026.

References and product information

General information only. A suggested date is not an appointment or a prescription; a healthcare professional confirms what you need. Clinical rules reviewed on 2026-09-27.

Explore care options